218 related articles for article (PubMed ID: 4145343)
21. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
22. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
23. Dopamine and noradrenaline transport into subcellular vesicles of the striatum.
Philippu A; Beyer J
Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(4):387-402. PubMed ID: 4269971
[No Abstract] [Full Text] [Related]
24. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
Moore KE
Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
[No Abstract] [Full Text] [Related]
25. The aggressive monoamines.
Eichelman BS; Thoa NB
Biol Psychiatry; 1973 Apr; 6(2):143-64. PubMed ID: 4736194
[No Abstract] [Full Text] [Related]
26. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
[No Abstract] [Full Text] [Related]
27. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
Ladinsky H; Consolo S; Bianchi S; Samanin R; Ghezzi D
Brain Res; 1975 Feb; 84(2):221-6. PubMed ID: 1111831
[TBL] [Abstract][Full Text] [Related]
28. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Vaatstra WJ; Eigeman L
Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
[No Abstract] [Full Text] [Related]
29. Inhibition of turning behaviour by clozapine in mice with unilateral destruction of dopaminergic nerve terminals.
Pycock CJ; Tarsy D; Marsden CD
J Pharm Pharmacol; 1975 Jun; 27(6):445-7. PubMed ID: 237097
[No Abstract] [Full Text] [Related]
30. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
Costall B; Naylor RJ; Pycock C
Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
[TBL] [Abstract][Full Text] [Related]
31. Proceedings: Drug-induced stereotyped behavior: similarities and differences.
Wallach MB
Psychopharmacol Bull; 1974 Jul; 10(3):12-3. PubMed ID: 4153704
[No Abstract] [Full Text] [Related]
32. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.
Thornburg JE; Moore KE
Neuropharmacology; 1974 Mar; 13(3):189-97. PubMed ID: 4858216
[No Abstract] [Full Text] [Related]
33. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
Sethy VH; VAN Woert MH
Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
[No Abstract] [Full Text] [Related]
34. Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine.
Melega WP; Raleigh MJ; Stout DB; Huang SC; Phelps ME
Behav Brain Res; 1997 Mar; 84(1-2):259-68. PubMed ID: 9079790
[TBL] [Abstract][Full Text] [Related]
35. Cliff jumping in rats after intravenous treatment with apomorphine.
Weissman A
Psychopharmacologia; 1971; 21(1):60-5. PubMed ID: 5567292
[No Abstract] [Full Text] [Related]
36. Functional compensation by transplantation of cell suspensions of embryonic mesencephalon into the striatum of rats with 6-hydroxydopamine lesions.
Watanabe H; Hiyama Y; Suda H; Sekihara S; Terasawa K
Jpn J Pharmacol; 1986 Apr; 40(4):591-3. PubMed ID: 3090330
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced circling after unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway is mediated via the midbrain periaqueductal grey and adjacent reticular formation (angular complex).
Reavill C; Leigh PN; Jenner P; Marsden CD
Life Sci; 1981 Dec; 29(23):2357-65. PubMed ID: 6798349
[No Abstract] [Full Text] [Related]
39. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
Schoenfeld RI; Uretsky NJ
J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
[No Abstract] [Full Text] [Related]
40. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
Algeri S; Cerletti C
Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
